Schmidt David 4

What Happened David Schmidt, a director of Astrana Health, was granted 4,525 restricted shares on June 10, 2026. The grant was reported at $0.00 per share (total reported value $0) and is an equity award (transaction code A) rather than an open‑market purchase or sale. The restricted shares vest on the earlier of June 10, 2027 or the date of the Issuer's 2027 annual meeting of stockholders.

Key Details

• Transaction date: June 10, 2026; Form 4 filed June 12, 2026 (timely filing).
• Transaction type: Grant / Award of restricted common stock (code A).
• Shares granted: 4,525 restricted shares at $0.00; reported value $0.
• Vesting: Earlier of June 10, 2027 or the 2027 annual meeting (per footnotes F1/F2).
• Shares owned after transaction: Total post‑transaction holdings not disclosed in the filing; filing notes the 4,525 restricted shares.
• No mention of 10b5‑1 plan, tax withholding, or immediate sale; not a derivative or exercise transaction.

Context Restricted stock awards to directors are a common form of compensation and generally vest over time, so these shares are not immediately tradable. Such grants are routine corporate compensation and do not by themselves indicate buying or selling sentiment in the market.